FHIR IG Statistics: ValueSet/HIV.D.DE90
Resources that use this resource
Resources that this resource uses
Narrative
Note: links and images are rebased to the (stated) source
- Include these codes as defined in
http://smart.who.int/hiv/CodeSystem/HIVConcepts
Code | Display | Definition |
HIV.D.DE91 | ABC + 3TC + ATV/r | Regimen containing abacavir, lamivudine, and atazanavir/ritonavir |
HIV.D.DE92 | ABC + 3TC + DTG | Regimen containing abacavir, lamivudine, and dolutegravir |
HIV.D.DE93 | ABC + 3TC + EFV | Regimen containing abacavir, lamivudine, and efavarinez |
HIV.D.DE94 | ABC + 3TC + LPV/r | Regimen containing abacavir, lamivudine, and lopinavir/ritonavir |
HIV.D.DE95 | ABC + 3TC + NVP | Regimen containing abacavir, lamivudine, and nevirapine |
HIV.D.DE96 | ABC + 3TC + RAL | Regimen containing abacavir, lamivudine, and raltegravir |
HIV.D.DE97 | AZT + 3TC + ATV/r | Regimen containing zidovudine, lamivudine, and atazanavir/ritonavir |
HIV.D.DE98 | AZT + 3TC + DRV/r | Regimen containing zidovudine, lamivudine, and darunavir/ritonavir |
HIV.D.DE99 | AZT + 3TC + DTG | Regimen containing zidovudine, lamivudine, and dolutegravir |
HIV.D.DE100 | AZT + 3TC + EFV | Regimen containing zidovudine, lamivudine, and efavirenz |
HIV.D.DE101 | AZT + 3TC + EFV 600 mg | Regimen containing zidovudine, lamivudine, and efavirenz 600 mg |
HIV.D.DE102 | AZT + 3TC + LPV/r | Regimen containing zidovudine, lamivudine, and lopinavir/ritonavir |
HIV.D.DE103 | AZT + 3TC + NVP | Regimen containing zidovudine, lamivudine, and nevirapine |
HIV.D.DE104 | AZT + 3TC + RAL | Regimen containing zidovudine, lamivudine, and raltegravir |
HIV.D.DE105 | TAF + 3TC + DTG | Regimen containing tenofovir alafenamide, lamivudine, and dolutegravir |
HIV.D.DE106 | TAF + FTC + DTG | Regimen containing tenofovir alafenamide, emtricitabine, and dolutegravir |
HIV.D.DE107 | TDF + 3TC + ATV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and atazanavir/ritonavir |
HIV.D.DE108 | TDF + 3TC + DRV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and darunavir/ritonavir |
HIV.D.DE109 | TDF + 3TC + DTG | Regimen containing tenofovir disoproxil fumarate, lamivudine, and dolutegravir |
HIV.D.DE110 | TDF + 3TC + EFV | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz |
HIV.D.DE111 | TDF + 3TC + EFV 400 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (400 mg) |
HIV.D.DE112 | TDF + 3TC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (600 mg) |
HIV.D.DE113 | TDF + 3TC + LPV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and lopinavir/ritonavir |
HIV.D.DE114 | TDF + 3TC + NVP | Regimen containing tenofovir disoproxil fumarate, lamivudine, and nevirapine |
HIV.D.DE115 | TDF + 3TC + PI/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and a boosted protease inhibitor |
HIV.D.DE116 | TDF + 3TC + RAL | Regimen containing tenofovir disoproxil fumarate, lamivudine, and raltegravir |
HIV.D.DE117 | TDF + FTC + ATV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and atazanavir/ritonavir |
HIV.D.DE118 | TDF + FTC + DRV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and darunavir/ritonavir |
HIV.D.DE119 | TDF + FTC + DTG | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and dolutegravir |
HIV.D.DE120 | TDF + FTC + EFV | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz |
HIV.D.DE121 | TDF + FTC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz (600 mg) |
HIV.D.DE122 | TDF + FTC + LPV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and lopinavir/ritonavir |
HIV.D.DE123 | TDF + FTC + NVP | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and nevirapine |
HIV.D.DE124 | TDF + FTC + PI/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and a boosted protease inhibitor |
HIV.D.DE125 | TDF + FTC + RAL | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and raltegravir |
HIV.D.DE126 | Other | Other regimen based upon WHO recommendations |
Source
{
"resourceType": "ValueSet",
"id": "HIV.D.DE90",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"
]
},
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"url": "http://smart.who.int/hiv/ValueSet/HIV.D.DE90",
"version": "0.4.4",
"name": "HIVDDE90",
"title": "ART regimen ValueSet",
"status": "active",
"experimental": true,
"date": "2025-07-24T19:24:35+00:00",
"publisher": "WHO",
"contact": [
{
"name": "WHO",
"telecom": [
{
"system": "url",
"value": "http://who.int"
}
]
}
],
"description": "Value set of list of ART regimens",
"compose": {
"include": [
{
"system": "http://smart.who.int/hiv/CodeSystem/HIVConcepts",
"concept": [
{
"code": "HIV.D.DE91",
"display": "ABC + 3TC + ATV/r"
},
{
"code": "HIV.D.DE92",
"display": "ABC + 3TC + DTG"
},
{
"code": "HIV.D.DE93",
"display": "ABC + 3TC + EFV"
},
{
"code": "HIV.D.DE94",
"display": "ABC + 3TC + LPV/r"
},
{
"code": "HIV.D.DE95",
"display": "ABC + 3TC + NVP"
},
{
"code": "HIV.D.DE96",
"display": "ABC + 3TC + RAL"
},
{
"code": "HIV.D.DE97",
"display": "AZT + 3TC + ATV/r"
},
{
"code": "HIV.D.DE98",
"display": "AZT + 3TC + DRV/r"
},
{
"code": "HIV.D.DE99",
"display": "AZT + 3TC + DTG"
},
{
"code": "HIV.D.DE100",
"display": "AZT + 3TC + EFV"
},
{
"code": "HIV.D.DE101",
"display": "AZT + 3TC + EFV 600 mg"
},
{
"code": "HIV.D.DE102",
"display": "AZT + 3TC + LPV/r"
},
{
"code": "HIV.D.DE103",
"display": "AZT + 3TC + NVP"
},
{
"code": "HIV.D.DE104",
"display": "AZT + 3TC + RAL"
},
{
"code": "HIV.D.DE105",
"display": "TAF + 3TC + DTG"
},
{
"code": "HIV.D.DE106",
"display": "TAF + FTC + DTG"
},
{
"code": "HIV.D.DE107",
"display": "TDF + 3TC + ATV/r"
},
{
"code": "HIV.D.DE108",
"display": "TDF + 3TC + DRV/r"
},
{
"code": "HIV.D.DE109",
"display": "TDF + 3TC + DTG"
},
{
"code": "HIV.D.DE110",
"display": "TDF + 3TC + EFV"
},
{
"code": "HIV.D.DE111",
"display": "TDF + 3TC + EFV 400 mg"
},
{
"code": "HIV.D.DE112",
"display": "TDF + 3TC + EFV 600 mg"
},
{
"code": "HIV.D.DE113",
"display": "TDF + 3TC + LPV/r"
},
{
"code": "HIV.D.DE114",
"display": "TDF + 3TC + NVP"
},
{
"code": "HIV.D.DE115",
"display": "TDF + 3TC + PI/r"
},
{
"code": "HIV.D.DE116",
"display": "TDF + 3TC + RAL"
},
{
"code": "HIV.D.DE117",
"display": "TDF + FTC + ATV/r"
},
{
"code": "HIV.D.DE118",
"display": "TDF + FTC + DRV/r"
},
{
"code": "HIV.D.DE119",
"display": "TDF + FTC + DTG"
},
{
"code": "HIV.D.DE120",
"display": "TDF + FTC + EFV"
},
{
"code": "HIV.D.DE121",
"display": "TDF + FTC + EFV 600 mg"
},
{
"code": "HIV.D.DE122",
"display": "TDF + FTC + LPV/r"
},
{
"code": "HIV.D.DE123",
"display": "TDF + FTC + NVP"
},
{
"code": "HIV.D.DE124",
"display": "TDF + FTC + PI/r"
},
{
"code": "HIV.D.DE125",
"display": "TDF + FTC + RAL"
},
{
"code": "HIV.D.DE126",
"display": "Other"
}
]
}
]
}
}